Cabergoline

🧮 Dose calculator

Hyperprolactinaemia · Regimen source: FDA Cabergoline · 2.2

• • Twice weekly (not daily). Increase by 0.25 mg twice weekly at intervals until prolactin normalises. FDA Cabergoline · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Cabergoline · 8.1

  “Clinical Considerations Maternal Adverse Reactions : In general, avoid use of dopamine agonists, including cabergoline tablets, during pregnancy and the postpartum period.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Cabergoline · 8.2

  “Risk Summary Cabergoline tablets is not recommended in postpartum women who are breastfeeding or who are planning to breastfeed.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Cabergoline · 8.4

  “Safety and effectiveness of cabergoline tablets in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cabergoline · 8.5

  “Clinical studies of cabergoline tablets did not include sufficient numbers of patients 65 years of age and older to determine whether they respond differently from younger adult patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.